Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

London pre-open: Stocks to edge up after mixed US session

(Sharecast News) - London stocks were set to nudge up at the open on Tuesday following a mixed close on Wall Street. The FTSE 100 was called to open around five points higher.

Ipek Ozkardeskaya, senior analyst at Swissquote Bank, said: "The selloff in Nvidia deepened yesterday and sent the shares into the correction territory following a 10% selloff. Nvidia shares erased around $430bn in market cap over the past three sessions.

"The selloff hit suddenly, right after the company stole the status of the world's most valuable company from Microsoft last week. There has been no bad news regarding the company's fundamentals on the newswire, no analyst downgrades, no soft forecasts, no rumours of slowing sales. It's just that the end of last quarter and the first half may have brought some investors to take some profit and go to the sidelines."

In UK corporate news, real estate group Landsec raised its stake in Kent's Bluewater Shopping Centre to 66.25% after a further £120m investment.

The company announced it had completed the acquisition of an additional 17.5% shareholding from Singaporean investment firm GIC. The deal raises Landsec's net rental income by £10.3m on an annualised basis.

AstraZeneca announced that a recent trial revealed that 'Imfinzi', or durvalumab, combined with chemotherapy, significantly enhanced event-free survival (EFS) and overall survival (OS) in patients with muscle-invasive bladder cancer (MIBC) compared to chemotherapy alone.

The pharmaceutical firm said the regimen, involving Imfinzi both before and after bladder removal surgery, was the first immunotherapy approach to successfully extend survival in bladder cancer patients.

It also confirmed that Imfinzi was well-tolerated, maintaining consistent safety profiles without increasing treatment discontinuation rates.

Share this article

Related Sharecast Articles

London open: Stocks little changed in early trading
(Sharecast News) - Stocks in the UK have started the session slightly lower, despite the record highs notched up overnight by the S&P 500 and Nasdaq Composite in the US.
London pre-open: Stocks set to dip at start of session
(Sharecast News) - Stocks in the UK look set to start slightly lower on Tuesday, despite the record highs notched up overnight by the S&P 500 and Nasdaq Composite in the US.
London close: FTSE 100 tops 9,000 as miners provide a boost
(Sharecast News) - UK stocks eked out another record close on Monday, with the FTSE 100 registering closing above the the 9,000-point mark for the first time in history.
London midday: Markets rangebound as FTSE 100 teeters near record highs
(Sharecast News) - UK stocks were struggling for direction on Monday, with the FTSE 100 continuing to test the elusive 9,000 level, though earlier modest gains were erased by the midday mark.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.